Will Moderna or Pfizer Have Better Phase 3 Covid-19 Vaccine Data? - Barron's
- Will Moderna or Pfizer Have Better Phase 3 Covid-19 Vaccine Data? Barron's
- Moderna and Pfizer’s COVID-19 vaccine candidates require ultra-low temperatures, raising questions about storage, distribution MarketWatch
- Philadelphia-area companies, researchers battling Covid-19 among recipients of $10 million in grants Philadelphia Business Journal
- Old fare as well as young in Moderna vaccine trial Reuters
- Moderna’s COVID-19 Vaccine Looks Promising, But Its Future Is Still Uncertain, Says J.P. Morgan Yahoo Finance
- View Full Coverage on Google News